-
Omada Health Analysts Say 'Buy' — While It's Still Below IPO Price
Tuesday, July 1, 2025 - 12:03pm | 326Canaccord Genuity and Needham analysts initiate coverage of Omada Health Inc (NASDAQ:OMDA) with a Buy rating. Canaccord Genuity analyst Richard Close assigns a price target of $27. Needham analyst Ryan MacDonald assigns a price target of $23. Check out other analyst stock ratings. Canaccord...
-
Tempus Could Gain Share In AI Health Care Market Poised To Grow By Over 30%
Tuesday, July 9, 2024 - 12:26pm | 454Tempus AI Inc (NASDAQ:TEM) announced last week it was granted advanced diagnostic laboratory test status for its next-generation sequencing assay. These analysts provide their initial takeaways from the stock. BofA Securities On Tempus Analyst Michael Ryskin initiated coverage with a Buy rating and...
-
Chegg AI Investments Not Translating To Improved Fundamentals, Analysts Dive Deeper Into Q4 Print
Tuesday, February 6, 2024 - 1:47pm | 499Shares of Chegg Inc (NYSE: CHGG) slipped in early trading on Tuesday, after declining more than 8% in the premarket session. The company reported its fourth-quarter results amid an exciting earnings season. Here are some key analyst takeaways from the release. Piper Sandler analyst Arvind Ramnani...
-
Chegg Needs To 'Dance In The Rain Without Getting Wet': 4 Analysts On Q1 Print
Tuesday, May 2, 2023 - 12:09pm | 441Shares of Chegg Inc (NYSE: CHGG) crashed in early trading on Tuesday, after the company said its business was hurt by ChatGPT. Piper Sandler On Chegg Analyst Arvind Ramnani reiterated a Neutral rating, while reducing the price target from $17 to $11. “CHGG reported modest upside to muted 1Q...
-
LivePerson Analysts Hug The Sidelines On Q4 Print, Lower Outlook
Thursday, March 16, 2023 - 12:17pm | 375Shares of LivePerson Inc (NASDAQ: LPSN) crashed in early trading on Thursday, after the company reported its fourth-quarter results. Needham analyst Ryan MacDonald maintained a Hold rating on the stock. KeyBanc Capital Markets analyst Thomas Blakey downgraded the rating from Overweight to Sector...
-
3 Chegg Analysts Are Disappointed With Guidance: Are ChatGBT, AI Apps A Threat?
Tuesday, February 7, 2023 - 12:48pm | 418Shares of education tech firm Chegg Inc (NYSE: CHGG) plummeted in early trading on Tuesday, after the company reported quarterly results and guidance. Total revenue for the fourth quarter hovered at around $205.2 million. That was slightly ahead of what was expected, $202 million. Meanwhile, Chegg...
-
This Chegg Analyst Says The Bear Case Is Off The Table
Monday, September 26, 2022 - 10:40am | 229Chegg Inc. (NYSE: CHGG) is well positioned to beat the conservative expectations for the third quarter and full year 2022, according to Needham. The Analyst: Ryan MacDonald upgraded the rating for Chegg from Hold to Buy, while establishing a price target of $28. The Thesis: The company’s...
-
8 Coupa Software Analysts Weigh In After Stock Spikes Following Upbeat Q2 Results
Wednesday, September 7, 2022 - 2:32pm | 856Shares of Coupa Software Inc (NASDAQ: COUP) spiked in Tuesday's after-hours session, after the company reported upbeat financial results and announced a $100 million buyback. Wells Fargo On Coupa Software Analyst Michael Turrin maintained an Equal-Weight rating, while reducing the price target...
-
5 Analysts Takeaways As Chegg's Stock Crashes After Q1 Earnings Report
Tuesday, May 3, 2022 - 12:57pm | 501Chegg Inc (NYSE: CHGG) reported its first-quarter adjusted earnings of 32 cents per share, ahead of the consensus estimates of 24 cents per share. Net revenues missed Street expectations and the company slashed its full-year revenue and adjusted EBITDA guidance. Piper Sandler On Chegg: Analyst...
-
Teladoc Analysts React To Shocking Q1 Losses, Rising BetterHelp Costs
Thursday, April 28, 2022 - 2:25pm | 494A brutal 12 months for Teladoc Health Inc (NYSE: TDOC) went from bad to much worse on Thursday when the stock dropped another 43% after the company reported much larger-than-expected losses in the first quarter and slashed its 2022 guidance. On Wednesday, Teladoc reported a whopping EPS loss of $41...
-
Teladoc Health Analysts Give Mixed Prognosis Following Q4 Earnings
Wednesday, February 23, 2022 - 1:25pm | 566Shares of Teladoc Health, Inc. (NYSE: TDOC) shares are lower after the telemedicine company issued below-consensus guidance for the first quarter. The Teladoc Analysts: Needham analyst Ryan MacDonald reiterated a Buy rating on Teladoc shares and reduced the price target from $170 to $100....
-
Coupa Software Stock Retreats On Q1 Results: Why Analysts Are Long-Term Bullish
Tuesday, June 8, 2021 - 4:54pm | 719Coupa Software Incorporated (NASDAQ: COUP) shares traded sharply lower Tuesday despite the company reporting better-than-expected first-quarter results. Here's what the Street had to say. The Coupa Analysts: Morgan Stanley analyst Stan Zlotsky maintained an Overweight rating on Coupa...
-
Chegg Analysts Bullish After Q1 Report: 'Balanced Subscriber Beat'
Tuesday, May 4, 2021 - 3:44pm | 519Chegg Inc (NYSE: CHGG) shares traded lower Tuesday after the company reported mixed first-quarter earnings numbers. For the first quarter, Chegg reported adjusted EPS of 28 cents, missing consensus analyst estimates of 31 cents. First-quarter revenue was $198.3 million, beating Wall Street...
-
'A COUR Growth Idea To Own': Analysts Initiate Coverage Of Coursera
Monday, April 26, 2021 - 1:13pm | 578Coursera Inc (NYSE: COUR) shares are up significantly since the company priced its late-March IPO at $33. The California company works with more than 200 universities to offer online courses and certifications. A boom in online education during the COVID-19 pandemic sent Coursera’s revenue...
-
Teladoc Health Stock Faces 'Durable Growth Opportunity': Here's Why
Thursday, April 15, 2021 - 12:36pm | 219Teladoc Health Inc (NYSE: TDOC) benefited from increased adoption of telehealth during the 2020 pandemic, according to Needham, and should be able to sustain this elevated growth “on the strength of its expansive platform.” The Teladoc Health Analyst: Ryan MacDonald initiated...